116 related articles for article (PubMed ID: 30082105)
1. Identification of influenza PA-Nter endonuclease inhibitors using pharmacophore- and docking-based virtual screening.
Ferro S; Gitto R; Buemi MR; Karamanou S; Stevaert A; Naesens L; De Luca L
Bioorg Med Chem; 2018 Aug; 26(15):4544-4550. PubMed ID: 30082105
[TBL] [Abstract][Full Text] [Related]
2. Metal-chelating 2-hydroxyphenyl amide pharmacophore for inhibition of influenza virus endonuclease.
Carcelli M; Rogolino D; Bacchi A; Rispoli G; Fisicaro E; Compari C; Sechi M; Stevaert A; Naesens L
Mol Pharm; 2014 Jan; 11(1):304-16. PubMed ID: 24206028
[TBL] [Abstract][Full Text] [Related]
3. Exploration of the 2,3-dihydroisoindole pharmacophore for inhibition of the influenza virus PA endonuclease.
Rogolino D; Naesens L; Bartoli J; Carcelli M; De Luca L; Pelosi G; Stokes RW; Van Berwaer R; Vittorio S; Stevaert A; Cohen SM
Bioorg Chem; 2021 Nov; 116():105388. PubMed ID: 34670331
[TBL] [Abstract][Full Text] [Related]
4. High-throughput docking for the identification of new influenza A virus polymerase inhibitors targeting the PA-PB1 protein-protein interaction.
Tintori C; Laurenzana I; Fallacara AL; Kessler U; Pilger B; Stergiou L; Botta M
Bioorg Med Chem Lett; 2014 Jan; 24(1):280-2. PubMed ID: 24314669
[TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of the binding pockets of the diketo acid inhibitor L-742,001 in the influenza virus PA endonuclease.
Stevaert A; Dallocchio R; Dessì A; Pala N; Rogolino D; Sechi M; Naesens L
J Virol; 2013 Oct; 87(19):10524-38. PubMed ID: 23824822
[TBL] [Abstract][Full Text] [Related]
6. An integrated biological approach to guide the development of metal-chelating inhibitors of influenza virus PA endonuclease.
Stevaert A; Nurra S; Pala N; Carcelli M; Rogolino D; Shepard C; Domaoal RA; Kim B; Alfonso-Prieto M; Marras SA; Sechi M; Naesens L
Mol Pharmacol; 2015 Feb; 87(2):323-37. PubMed ID: 25477342
[TBL] [Abstract][Full Text] [Related]
7. Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease Inhibitors.
Jones JC; Kumar G; Barman S; Najera I; White SW; Webby RJ; Govorkova EA
mBio; 2018 Apr; 9(2):. PubMed ID: 29691337
[TBL] [Abstract][Full Text] [Related]
8. Virtual Screening and Biological Validation of Novel Influenza Virus PA Endonuclease Inhibitors.
Pala N; Stevaert A; Dallocchio R; Dessì A; Rogolino D; Carcelli M; Sanna V; Sechi M; Naesens L
ACS Med Chem Lett; 2015 Aug; 6(8):866-71. PubMed ID: 26288686
[TBL] [Abstract][Full Text] [Related]
9. Flupyranochromene, a novel inhibitor of influenza virus cap-dependent endonuclease, from Penicillium sp. f28743.
Yamasaki M; Igarashi M; Sawa R; Nosaka C; Umekita M; Hatano M; Kimura T; Iijima K; Takizawa N; Kato T; Mizumoto K; Nomoto A
J Antibiot (Tokyo); 2019 Mar; 72(3):125-133. PubMed ID: 30622294
[TBL] [Abstract][Full Text] [Related]
10. N-acylhydrazone inhibitors of influenza virus PA endonuclease with versatile metal binding modes.
Carcelli M; Rogolino D; Gatti A; De Luca L; Sechi M; Kumar G; White SW; Stevaert A; Naesens L
Sci Rep; 2016 Aug; 6():31500. PubMed ID: 27510745
[TBL] [Abstract][Full Text] [Related]
11. Design of the influenza virus inhibitors targeting the PA endonuclease using 3D-QSAR modeling, side-chain hopping, and docking.
Yan Z; Zhang L; Fu H; Wang Z; Lin J
Bioorg Med Chem Lett; 2014 Jan; 24(2):539-47. PubMed ID: 24365156
[TBL] [Abstract][Full Text] [Related]
12. Mutational and metal binding analysis of the endonuclease domain of the influenza virus polymerase PA subunit.
Crépin T; Dias A; Palencia A; Swale C; Cusack S; Ruigrok RW
J Virol; 2010 Sep; 84(18):9096-104. PubMed ID: 20592097
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of PA endonuclease activity of influenza virus RNA polymerase by Kampo medicines.
Shirayama R; Shoji M; Sriwilaijaroen N; Hiramatsu H; Suzuki Y; Kuzuhara T
Drug Discov Ther; 2016; 10(2):109-13. PubMed ID: 26902927
[TBL] [Abstract][Full Text] [Related]
14. Fragment-Based Identification of Influenza Endonuclease Inhibitors.
Credille CV; Chen Y; Cohen SM
J Med Chem; 2016 Jul; 59(13):6444-54. PubMed ID: 27291165
[TBL] [Abstract][Full Text] [Related]
15. Biochemical characterization of recombinant influenza A polymerase heterotrimer complex: Endonuclease activity and evaluation of inhibitors.
Xing W; Barauskas O; Kirschberg T; Niedziela-Majka A; Clarke M; Birkus G; Weissburg P; Liu X; Schultz BE; Sakowicz R; Kwon H; Feng JY
PLoS One; 2017; 12(8):e0181969. PubMed ID: 28809961
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the salicylaldehyde thiosemicarbazone scaffold for inhibition of influenza virus PA endonuclease.
Rogolino D; Bacchi A; De Luca L; Rispoli G; Sechi M; Stevaert A; Naesens L; Carcelli M
J Biol Inorg Chem; 2015 Oct; 20(7):1109-21. PubMed ID: 26323352
[TBL] [Abstract][Full Text] [Related]
17. Unraveling the anti-influenza effect of flavonoids: Experimental validation of luteolin and its congeners as potent influenza endonuclease inhibitors.
Zima V; Radilová K; Kožíšek M; Albiñana CB; Karlukova E; Brynda J; Fanfrlík J; Flieger M; Hodek J; Weber J; Majer P; Konvalinka J; Machara A
Eur J Med Chem; 2020 Dec; 208():112754. PubMed ID: 32883638
[TBL] [Abstract][Full Text] [Related]
18. Identification of Influenza PA
Zhang C; Xiang J; Xie Q; Zhao J; Zhang H; Huang E; Shaw P; Liu X; Hu C
Molecules; 2021 Nov; 26(23):. PubMed ID: 34885710
[TBL] [Abstract][Full Text] [Related]
19. Structural and biochemical basis for development of influenza virus inhibitors targeting the PA endonuclease.
DuBois RM; Slavish PJ; Baughman BM; Yun MK; Bao J; Webby RJ; Webb TR; White SW
PLoS Pathog; 2012; 8(8):e1002830. PubMed ID: 22876176
[TBL] [Abstract][Full Text] [Related]
20. Identification of a small-molecule inhibitor of influenza virus via disrupting the subunits interaction of the viral polymerase.
Yuan S; Chu H; Zhao H; Zhang K; Singh K; Chow BK; Kao RY; Zhou J; Zheng BJ
Antiviral Res; 2016 Jan; 125():34-42. PubMed ID: 26593979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
